news
Massachusetts Psychedelic Legalization Initiative Advances to Ballot
BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle
BetterLife Pharma Set to Begin Human Trials for LSD Derivative
Numinus Plans to Refocus on U.S. Market, Considers Divesting Canadian Operations
![Cybin Patent Cybin Patent](https://psychedelicmedicalnews.com/wp-content/uploads/2024/04/Cybin-Patent-500x300.jpg)